|Videos|July 26, 2019
James W. Wheless, MD: Making Treatment Decisions in Epilepsy
Author(s)James W. Wheless, MD
The professor and chief of pediatric neurology at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center discussed the decision-making process for choosing interventions for patients with epilepsy, and how to keep patients adherent.
Advertisement
“If I’m treating my seasonal allergies and I forget to take my antihistamine, I might sneeze more, but the risk is not so high. If I have seizure medicine that I’m supposed to take every day and I forget a couple days, then it’s high risk. If I have a seizure while I’m driving or at work—it’s a whole different risk factor.”
At the 2019 International Epilepsy Congress , June 22-26, in Bangkok, Thailand, NeurologyLive® spoke with James W. Wheless, MD, about one of the complicated nature of treating and managing patients with epilepsy. With a number of available interventions ranging from the dietary to pharmacokinetic to surgical, combined with the complexity of the disease and high rates of refractory patients, there can be wide variations in treatment regimens.
The professor and chief of pediatric neurology at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center spoke about the process of determining when a patient might benefit from monotherapy or polytherapy, and how physicians navigate those treatment decisions.
Wheless also shared his insight into addressing the challenges of patient adherence, which, despite its vital nature in epilepsy, is quite poor in that patient population. Adherence is a particular challenge, he said, due to the high risk of seizures that couples with poor adherence. According to Wheless, producing strategies to aid patients in maintaining high adherence and educating patients on its importance is the first step.
For more coverage of IEC 2019, click here .
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025
- NeurologyLive® Brain Games: September 14, 2025
September 14th 2025
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
Latest CME
Advertisement
Advertisement